The drugmakers developing the vaccine candidates now in the final stage of clinical testing — Pfizer, Moderna, AstraZeneca and Johnson & Johnson — all told Business Insider they plan to test their vaccines in children, but none gave an estimated timeline of when a vaccine could become available for children.
Moderna shared its plans to begin a pediatric trial with Business Insider, saying it hopes to get one underway by the end of 2020, pending regulatory approval.
“Right now I’m pretty worried that we won’t have a vaccine available for kids by the start of next school year,” Evan Anderson, MD, an Atlanta pediatrician, told The New York Times.
More articles on pharmacy:
Novartis sells $2.1B in bonds to increase access to its drugs in disadvantaged countries
FDA proposes change to rule on off-label drug use
Gilead settles kickback allegations for $97M
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
